Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

NXGL

Nexgel Inc

Sep 20 • 03:08PM ET

2.64

Dollar change +0.12
Percentage change 4.76	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VXF VTI

Index	-	P/E	-	EPS (ttm)	-0.57	Insider Own	22.10%	Shs Outstand	5.74M	Perf Week	-2.94%
Market Cap	17.87M	Forward P/E	-	EPS next Y	-0.01	Insider Trans	3.46%	Shs Float	5.27M	Perf Month	0.00%
Income	-3.39M	PEG	-	EPS next Q	-0.12	Inst Own	2.16%	Short Float	0.30%	Perf Quarter	22.79%
Sales	5.01M	P/S	3.57	EPS this Y	5.36%	Inst Trans	12.22%	Short Ratio	0.32	Perf Half Y	-0.38%
Book/sh	0.66	P/B	4.01	EPS next Y	98.11%	ROA	-33.40%	Short Interest	0.02M	Perf Year	25.71%
Cash/sh	0.16	P/C	16.70	EPS next 5Y	-	ROE	-65.44%	52W Range	1.46 - 3.24	Perf YTD	23.94%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-49.92%	52W High	-18.52%	Beta	0.77
Dividend TTM	-	Quick Ratio	0.81	Sales past 5Y	37.64%	Gross Margin	19.70%	52W Low	80.82%	ATR (14)	0.17
Dividend Ex-Date	-	Current Ratio	1.36	EPS Y/Y TTM	5.30%	Oper. Margin	-74.98%	RSI (14)	47.66	Volatility	6.02% 5.62%
Employees	19	Debt/Eq	0.72	Sales Y/Y TTM	73.98%	Profit Margin	-67.60%	Recom	1.00	Target Price	6.00
Option/Short	No / Yes	LT Debt/Eq	0.63	EPS Q/Q	-15.32%	Payout	-	Rel Volume	0.30	Prev Close	2.52
Sales Surprise	2.50%	EPS Surprise	0.00%	Sales Q/Q	23.39%	Earnings	Aug 14 AMC	Avg Volume	49.47K	Price	2.64
SMA20	-3.47%	SMA50	-1.06%	SMA200	10.62%	Trades		Volume	13,138	Change	4.76%

Sep-18-24 09:00AM	NEXGEL's Beauty Brand, Silly George, Partners with Multi-Talented Artist and Entrepreneur, James Maslow, to Promote Innovative Eyelash Collection (GlobeNewswire)
Aug-14-24 04:25PM	NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million (GlobeNewswire) -5.61%
Aug-12-24 09:15AM	NEXGEL to Report Second Quarter 2024 Financial Results on August 14th (GlobeNewswire)
09:00AM	NEXGEL Announces $1,110,000 Registered Direct Offering Led by Insiders (GlobeNewswire)
Jul-18-24 09:15AM	NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal (GlobeNewswire)
04:05PM	Loading…
Jul-08-24 04:05PM	NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively (GlobeNewswire) -7.69% +9.31%
Jun-27-24 09:00AM	NEXGEL Subsidiary, CG Converting and Packaging, Announces it will Supply SilverSeal to Cintas Corporation (GlobeNewswire)
Jun-11-24 08:40AM	NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America (GlobeNewswire)
May-16-24 09:00AM	NEXGEL Acquires International Beauty Brand, Silly George (GlobeNewswire)
May-13-24 08:53PM	NXGL Stock Earnings: NexGel Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year (GlobeNewswire)
May-09-24 08:00AM	NEXGEL to Report First Quarter 2024 Financial Results on May 13th (GlobeNewswire)
May-06-24 04:05PM	NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024 (GlobeNewswire)
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-18-24 08:00AM	NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024 (GlobeNewswire)
10:28AM	Loading…
Apr-02-24 10:28AM	NEXGEL, Inc. (NASDAQ:NXGL) Q4 2023 Earnings Call Transcript (Insider Monkey) +6.25%
Apr-01-24 12:52PM	NXGL Stock Earnings: NexGel Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -17.95%
07:50AM	NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year (GlobeNewswire)
Mar-27-24 09:00AM	NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday (GlobeNewswire)
Mar-21-24 09:00AM	NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th (GlobeNewswire)
Mar-11-24 11:00AM	RETRANSMISSION: iAccess Alpha's Buyside Best Ideas Spring Virtual Conference March 12th and 13th, 2024 (ACCESSWIRE)
Mar-04-24 08:30AM	NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th (GlobeNewswire) +15.53%
Feb-21-24 04:05PM	NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders (GlobeNewswire) +16.83%
Jan-18-24 09:00AM	NEXGEL to Present at The Microcap Conference, January 30th through February 1st (GlobeNewswire)
Jan-09-24 08:30AM	NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024 (GlobeNewswire)
Dec-11-23 08:00AM	NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America (GlobeNewswire) +7.87%
Dec-05-23 08:00AM	NEXGEL Acquires Kenkoderm Psoriasis Skincare Line (GlobeNewswire)
Nov-20-23 10:00AM	NEXGEL, Inc. (NASDAQ:NXGL) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-16-23 06:35AM	3 Stocks Youll Regret Not Buying Soon: November 2023 (InvestorPlace)
Nov-13-23 04:05PM	NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year (GlobeNewswire)
09:00AM	Loading…
Nov-02-23 09:00AM	NEXGEL to Report Third Quarter 2023 Financial Results on November 13th (GlobeNewswire)
Oct-30-23 08:00AM	NEXGEL Secures Supply Agreement with AbbVie (GlobeNewswire)
Sep-26-23 09:49AM	NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd (GlobeNewswire)
Sep-15-23 11:02AM	Director Scott Henry Acquires 10,500 Shares of NexGel Inc (GuruFocus.com) -8.89%
Aug-14-23 04:05PM	NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-Year (GlobeNewswire) -5.91%
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
Aug-10-23 06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research) -11.22%
Aug-09-23 06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research) -12.13%
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research) +8.14%
Aug-02-23 09:00AM	NEXGEL to Report Second Quarter 2023 Financial Results on August 14th (GlobeNewswire) -6.36%
07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research)
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research)
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research) +14.08%
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research) -7.02%
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research) +6.54%
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research)
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research) -5.78%
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
Jul-19-23 09:10AM	NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America (GlobeNewswire)
07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research)
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research)
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research)
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research)
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research)
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research)
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research)
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research)
Jun-28-23 06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research) -5.30%
Jun-26-23 06:41AM	Daily Vickers Top Insider Picks for 06/26/2023 (Argus Research) +6.39%
Jun-23-23 09:24AM	Daily Vickers Top Insider Picks for 06/23/2023 (Argus Research)
Jun-22-23 07:05AM	Daily Vickers Top Insider Picks for 06/22/2023 (Argus Research)
Jun-21-23 07:05AM	Daily Vickers Top Insider Picks for 06/21/2023 (Argus Research) +15.22%
Jun-20-23 06:35AM	Daily Vickers Top Insider Picks for 06/20/2023 (Argus Research)
Jun-15-23 09:00AM	NEXGEL to Participate in Maxim Groups Virtual Healthcare Conference on June 20th (GlobeNewswire)
06:38AM	Daily Vickers Top Insider Picks for 06/15/2023 (Argus Research)
Jun-14-23 06:39AM	Daily Vickers Top Insider Picks for 06/14/2023 (Argus Research) -6.13%
Jun-13-23 06:37AM	Daily Vickers Top Insider Picks for 06/13/2023 (Argus Research)
Jun-12-23 06:47AM	Daily Vickers Top Insider Picks for 06/12/2023 (Argus Research) +6.69%
May-24-23 09:00AM	NEXGEL to Participate in the LD Micro Invitational XIII on June 6th (GlobeNewswire)
May-15-23 04:05PM	NEXGEL Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-09-23 09:15AM	NEXGEL to Report First Quarter 2023 Financial Results on May 15th (GlobeNewswire)
Mar-30-23 06:44AM	NEXGEL Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.) +5.43%
Mar-27-23 04:05PM	NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) -16.31%
Mar-15-23 07:30AM	NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th (GlobeNewswire)
Mar-07-23 07:30AM	NEXGEL Partners with Former Major League Lacrosse Player, Greg The Beast Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard (GlobeNewswire)
Mar-02-23 08:30AM	NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business (GlobeNewswire) +7.14%
Jan-17-23 07:30AM	NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee (PR Newswire)
Dec-27-22 11:40AM	Hydrogel maker Nexgel targets sports teams and athletes with new product for turf burns (American City Business Journals) -13.24%
Dec-08-22 07:30AM	NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds (GlobeNewswire) -11.69%
Dec-07-22 07:30AM	NEXGEL Announces Share Repurchase Program (PR Newswire) +28.33%
Dec-01-22 11:00AM	NEXGEL to Host Fireside Chat with CEO Adam Levy on December 14th at 11:00 a.m. ET (PR Newswire)
Nov-08-22 04:11PM	NEXGEL Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-02-22 09:00AM	NEXGEL to Report Third Quarter 2022 Financial Results on November 8th (GlobeNewswire) +6.78%
Oct-25-22 11:52AM	NexGel Highlights Positive Data From Proof-of-Concept Study For Its Diclofenac Hydrogel Pain Treatment (Benzinga)
08:00AM	NEXGEL Reports Positive Results from Proof-of-Concept Study for its Diclofenac Hydrogel Pain Treatment (GlobeNewswire)
Oct-20-22 08:00AM	NEXGEL Develops New Hydrogel Patch to Treat Amblyopia (GlobeNewswire)
Oct-04-22 07:30AM	NEXGEL to Participate in Upcoming Investor Conferences in October 2022 (GlobeNewswire)
Oct-03-22 07:30AM	SAGE Journals Publishes New Data Revealing NEXGELs SilverSeal Hydrogel Dressing Improves Postsurgical Scarring (GlobeNewswire)
Sep-29-22 07:30AM	NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board (GlobeNewswire) -6.58%
Sep-07-22 07:30AM	NEXGEL to Present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022 (GlobeNewswire)

NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The company was founded on January 13, 2009 and is headquartered in Langhorne, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stein John Nachum	Director	Aug 23 '24	Buy	2.50	10,000	25,000	471,820	Aug 28 05:00 PM
glassman steven mark	Director	Aug 23 '24	Buy	2.50	10,000	25,000	145,025	Aug 27 09:14 PM
ZELDIS JEROME B	Director	Aug 23 '24	Buy	2.50	10,000	25,000	103,028	Aug 27 09:13 PM
Henry Scott Robert	Director	Aug 23 '24	Buy	2.50	10,000	25,000	145,735	Aug 27 09:11 PM
Drapczuk Adam E III	Chief Financial Officer	Aug 23 '24	Buy	2.50	10,000	25,000	57,394	Aug 27 09:09 PM
Henry Scott Robert	Director	Mar 01 '24	Buy	2.11	23,697	50,001	135,735	Mar 05 09:07 AM
glassman steven mark	Director	Mar 01 '24	Buy	2.11	11,848	24,999	135,025	Mar 05 09:05 AM
Drapczuk Adam E III	Chief Financial Officer	Mar 01 '24	Buy	2.11	47,394	100,001	47,394	Mar 05 09:04 AM
glassman steven mark	Director	Dec 22 '23	Buy	2.20	3,885	8,535	123,177	Dec 26 04:15 PM
Stein John Nachum	Director	Sep 26 '23	Buy	1.96	2,500	4,900	500,019	Sep 28 05:28 PM

Open in Screener

PTCT

PTC Therapeutics Inc

Sep 20 • 03:09PM ET

37.01

Dollar change +0.85
Percentage change 2.34	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

PTCT PTC Therapeutics Inc daily Stock Chart

Held by: VTI IWM VB VXF XBI VBK IBB IWO SCHA VTWO

Index	RUT	P/E	-	EPS (ttm)	-6.32	Insider Own	3.29%	Shs Outstand	75.71M	Perf Week	8.87%
Market Cap	2.85B	Forward P/E	-	EPS next Y	-4.15	Insider Trans	-1.11%	Shs Float	74.40M	Perf Month	9.06%
Income	-479.52M	PEG	-	EPS next Q	-1.51	Inst Own	103.39%	Short Float	7.56%	Perf Quarter	1.33%
Sales	900.45M	P/S	3.16	EPS this Y	37.58%	Inst Trans	2.02%	Short Ratio	8.21	Perf Half Y	22.65%
Book/sh	-12.75	P/B	-	EPS next Y	20.59%	ROA	-29.47%	Short Interest	5.63M	Perf Year	44.95%
Cash/sh	14.21	P/C	2.60	EPS next 5Y	-9.51%	ROE	-	52W Range	17.53 - 40.69	Perf YTD	34.27%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-24.94%	ROI	-	52W High	-9.06%	Beta	0.65
Dividend TTM	-	Quick Ratio	2.17	Sales past 5Y	29.08%	Gross Margin	71.23%	52W Low	111.10%	ATR (14)	1.58
Dividend Ex-Date	-	Current Ratio	2.23	EPS Y/Y TTM	25.01%	Oper. Margin	-21.37%	RSI (14)	68.12	Volatility	4.06% 4.28%
Employees	995	Debt/Eq	-	Sales Y/Y TTM	9.98%	Profit Margin	-53.25%	Recom	2.47	Target Price	39.71
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	51.43%	Payout	-	Rel Volume	0.59	Prev Close	36.16
Sales Surprise	1.87%	EPS Surprise	-15.19%	Sales Q/Q	-12.68%	Earnings	Aug 08 AMC	Avg Volume	685.43K	Price	37.01
SMA20	9.42%	SMA50	11.12%	SMA200	20.35%	Trades		Volume	354,018	Change	2.34%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-04-24	Initiated	Robert W. Baird	Outperform	$44
Aug-26-24	Resumed	UBS	Buy	$47
May-20-24	Upgrade	Raymond James	Underperform → Mkt Perform
Dec-19-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$28
Dec-08-23	Initiated	Wells Fargo	Overweight	$37
Oct-30-23	Upgrade	Oppenheimer	Perform → Outperform	$165
Oct-27-23	Downgrade	Citigroup	Neutral → Sell	$29 → $17
Oct-06-23	Downgrade	Truist	Buy → Hold	$45 → $25
Sep-18-23	Downgrade	Citigroup	Buy → Neutral	$55 → $28
Sep-15-23	Downgrade	Raymond James	Outperform → Underperform
Mar-17-23	Initiated	SVB Securities	Market Perform	$48
Dec-14-22	Initiated	Goldman	Sell	$35
Sep-12-22	Initiated	Jefferies	Buy	$62
Sep-09-22	Initiated	Morgan Stanley	Equal-Weight	$54
Sep-01-22	Initiated	Citigroup	Buy	$70
Apr-04-22	Resumed	Cantor Fitzgerald	Overweight	$64 → $63
Oct-18-21	Downgrade	BofA Securities	Neutral → Underperform	$38
Apr-26-21	Resumed	Credit Suisse	Neutral	$54
Mar-29-21	Upgrade	RBC Capital Mkts	Underperform → Sector Perform	$47
Feb-12-21	Downgrade	BofA Securities	Buy → Neutral

Show Previous Ratings

Sep-12-24 04:30PM	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Aug-28-24 04:30PM	PTC Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Aug-19-24 03:33PM	PTC Therapeutics Stock Earns RS Rating Upgrade To 83 (Investor's Business Daily)
Aug-08-24 05:15PM	PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:09PM	PTC Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Loading…
04:01PM	PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results (PR Newswire)
Aug-06-24 09:15AM	Unlocking Q2 Potential of PTC Therapeutics (PTCT): Exploring Wall Street Estimates for Key Metrics (Zacks)
Jul-30-24 08:00AM	PTC Therapeutics Announces Sepiapterin NDA Submission to FDA (PR Newswire)
Jul-25-24 04:30PM	PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results (PR Newswire)
10:02AM	Will PTC Therapeutics (PTCT) Report Negative Q2 Earnings? What You Should Know (Zacks)
Jul-01-24 08:00AM	PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug (Zacks)
Jun-28-24 04:08PM	PTC's Journey Of 'Twist And Doubt' Continues With Another Rejection; Shares Tumble (Investor's Business Daily) -11.77%
08:53AM	PTC Therapeutics Tumbles After European Regulators Reject Its Drug Again (Investor's Business Daily)
07:49AM	PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar (BioPharma Dive)
06:00AM	CHMP Issues Negative Opinion on Translarna Following European Commission Request for Review (PR Newswire)
04:44AM	Loading…
Jun-24-24 04:44AM	PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock? (Zacks)
Jun-21-24 04:30PM	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire) +9.70%
Jun-20-24 08:19AM	FDA lifts hold on PTC Huntingtons disease trial (BioPharma Dive) -6.54%
06:30AM	Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients (PR Newswire)
Jun-04-24 06:00AM	The 3 Most Undervalued Biotech Stocks to Buy in June 2024 (InvestorPlace)
May-29-24 08:00AM	PTC Therapeutics to Participate at Upcoming Investor Conference (PR Newswire)
May-28-24 08:30AM	PTC Therapeutics Announces Validation of Sepiapterin European MAA (PR Newswire)
May-25-24 02:41AM	Insider Sale: Director Jerome Zeldis Sells 20,000 Shares of PTC Therapeutics Inc (PTCT) (GuruFocus.com)
May-21-24 12:26PM	PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug (Zacks)
10:34AM	Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating (MT Newswires)
May-20-24 04:05PM	PTC Therapeutics Stock Soars As Its Biggest Drug 'Lives To Fight Another Day' (Investor's Business Daily) +21.23%
12:36PM	Raymond James Upgrades PTC Therapeutics to Market Perform From Underperform (MT Newswires)
12:20PM	PTC Therapeutics Announces European Commission Returns Translarna Opinion to CHMP For Re-evaluation (PR Newswire)
08:57AM	Sector Update: Health Care (MT Newswires)
08:45AM	PTC Therapeutics Says European Commission Seeking Review of Negative Opinion on Translarna (MT Newswires)
07:45AM	Loading…
07:45AM	European Commission, in unprecedented move, declines to revoke approval of PTC Duchenne drug (BioPharma Dive)
May-14-24 09:10AM	Sector Update: Health Care Stocks Steady Premarket Tuesday (MT Newswires)
08:51AM	Sector Update: Health Care (MT Newswires)
08:26AM	PTC Therapeutics Gets FDA Priority Review for Upstaza Biologics License Application (MT Newswires)
07:30AM	PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza (PR Newswire)
May-02-24 08:00AM	PTC Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
May-01-24 02:45PM	PTC Therapeutics Stock Sees IBD RS Rating Climb To 72 (Investor's Business Daily) +6.25%
Apr-30-24 12:25PM	PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-29-24 06:11AM	Morgan Stanley Upgrades PTC Therapeutics to Equalweight From Underweight, Adjusts PT to $30 From $28 (MT Newswires) +12.50%
Apr-26-24 03:57PM	Sector Update: Health Care Stocks Edge Higher Late Afternoon (MT Newswires) +12.08%
11:16AM	PTC Therapeutics Shares Rise After Better-Than-Expected Q1 Results (MT Newswires)
07:11AM	Q1 2024 PTC Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
03:35AM	PTC Therapeutics Inc (PTCT) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ... (GuruFocus.com)
Apr-25-24 08:56PM	PTCT Stock Earnings: PTC Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:00PM	Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics (Zacks)
05:39PM	PTC Therapeutics Q1 2024 Earnings: A Detailed Financial Review (GuruFocus.com)
04:53PM	PTC Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results (PR Newswire)
Apr-23-24 04:30PM	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Apr-18-24 10:01AM	PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Apr-11-24 08:00AM	PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results (PR Newswire)
Mar-28-24 08:30AM	PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA (PR Newswire)
Mar-25-24 10:00AM	A Comprehensive Look at Sarepta's Growth and Innovation (GuruFocus.com)
Mar-20-24 02:00PM	PTC Therapeutics (PTCT) Up on Positive Regulatory Updates (Zacks)
Mar-19-24 07:30AM	PTC Therapeutics Provides Key Regulatory Updates (PR Newswire)
Mar-02-24 08:56AM	PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 06:51AM	Q4 2023 PTC Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) +13.34%
Feb-29-24 06:00PM	Here's What Key Metrics Tell Us About PTC Therapeutics (PTCT) Q4 Earnings (Zacks)
05:20PM	PTC Therapeutics (PTCT) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:33PM	PTC Therapeutics Inc (PTCT) Reports Robust Revenue Growth and Advances in Pipeline (GuruFocus.com)
04:30PM	PTC Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Feb-27-24 05:20PM	PTC Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Feb-26-24 09:16AM	Wall Street's Insights Into Key Metrics Ahead of PTC Therapeutics (PTCT) Q4 Earnings (Zacks)
Feb-22-24 04:30PM	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Feb-15-24 08:00AM	PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Feb-13-24 10:00AM	PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks) -6.83%
Feb-11-24 01:45AM	1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock? (Motley Fool)
Jan-26-24 04:06PM	PTC Therapeutics Recovers From An Ugly Fall After European Officials Reject DMD Drug (Investor's Business Daily)
11:45AM	PTC Therapeutics Recovers, Mostly, After European Officials Reject DMD Drug (Investor's Business Daily)
10:18AM	PTC Therapeutics Flashes A Bearish Sign After European Officials Reject DMD Drug (Investor's Business Daily)
Jan-25-24 04:51PM	UPDATE 1-Europe to withdraw PTC Therapeutics' rare muscle disorder drug (Reuters)
04:20PM	PTC Therapeutics' muscle disorder drug fails to secure EU regulator backing (Reuters)
04:05PM	CHMP Issues Negative Opinion for Renewal of Conditional Marketing Authorization for Translarna (ataluren) Following Re-examination Procedure (PR Newswire)
Jan-24-24 07:02PM	PTC Therapeutics Inc Director Allan Jacobson Sells 10,000 Shares (GuruFocus.com)
Jan-12-24 01:02AM	PTC Therapeutics Inc Chief Business Officer Eric Pauwels Sells 3,634 Shares (GuruFocus.com) -5.01%
Jan-08-24 09:26AM	PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire) +7.49%
Jan-03-24 08:00AM	PTC Therapeutics to Participate at 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-20-23 09:41AM	Analysts on Wall Street Lower Ratings for These 5 Stocks (Insider Monkey)
Dec-15-23 05:01PM	Insider Buying: CFO Pierre Gravier Acquires 7,700 Shares of PTC Therapeutics Inc (PTCT) (GuruFocus.com)
Dec-14-23 04:30PM	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Dec-05-23 04:15PM	PTC Therapeutics Provides Updates on Translarna Regulatory Activities (PR Newswire)
Nov-14-23 03:58PM	FMR LLC Trims Stake in PTC Therapeutics Inc (GuruFocus.com) +9.71%
Nov-03-23 04:30PM	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire) +8.08%
Oct-30-23 09:03AM	PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-27-23 11:22AM	Q3 2023 PTC Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -22.71%
10:01AM	Roblox upgraded, Bristol Myers downgraded: Wall Street's top analyst calls (The Fly)
08:33AM	Why Is PTC Therapeutics (PTCT) Stock Down 23% Today? (InvestorPlace)
07:15AM	The Zacks Analyst Blog Highlights Bristol Myers, PTC Therapeutics, Beam Therapeutics and BioMarin Pharmaceutical (Zacks)
02:38AM	Southwest Airlines slashed at TD Cowen following Q3 miss: 4 big analyst cuts (Investing.com)
Oct-26-23 07:30PM	PTC Therapeutics (PTCT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:10PM	PTC Therapeutics Inc (PTCT) Reports Q3 2023 Earnings: Revenue of $197 Million (GuruFocus.com)
05:30PM	PTC Therapeutics (PTCT) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:25PM	PTC Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	PTC Therapeutics Provides Corporate Update and Reports Third Quarter Financial Results (PR Newswire)
Oct-24-23 10:00AM	Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-19-23 07:02PM	Why PTC Therapeutics Soared 15% Higher Today (Motley Fool) +14.98%
10:01AM	PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
08:00AM	PTC Therapeutics Announces Evrysdi Royalty Agreement with Royalty Pharma for Up To $1.5 Billion (PR Newswire)
Oct-16-23 04:30PM	PTC Therapeutics to Host Conference Call to DiscussThird Quarter 2023 Financial Results (PR Newswire)

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gravier Pierre	CHIEF FINANCIAL OFFICER	Jul 16 '24	Sale	34.02	2,269	77,200	53,531	Jul 18 05:20 PM
ZELDIS JEROME B	Director	May 22 '24	Option Exercise	26.42	20,000	528,400	34,500	May 24 05:20 PM
ZELDIS JEROME B	Director	May 22 '24	Sale	38.24	20,000	764,800	14,500	May 24 05:20 PM
Golden Lee Scott	EVP & CHIEF MEDICAL OFFICER	May 07 '24	Sale	32.82	175	5,744	59,813	May 08 05:20 PM
Klein Matthew B.	CHIEF EXECUTIVE OFFICER	Apr 19 '24	Sale	24.89	3,361	83,669	225,807	Apr 22 05:20 PM
Pauwels Eric	CHIEF EXECUTIVE OFFICER	Apr 17 '24	Sale	25.14	787	19,781	67,694	Apr 19 05:20 PM
Klein Matthew B.	CHIEF EXECUTIVE OFFICER	Apr 17 '24	Sale	25.14	1,307	32,851	229,168	Apr 19 05:20 PM
Golden Lee Scott	EVP & CHIEF MEDICAL OFFICER	Apr 02 '24	Sale	28.37	526	14,923	59,988	Apr 04 05:16 PM
Almstead Neil Gregory	CHIEF TECHNICAL OPS OFFICER	Jan 30 '24	Sale	27.25	618	16,841	61,202	Feb 01 04:18 PM
Almstead Neil Gregory	CHIEF TECHNICAL OPS OFFICER	Jan 30 '24	Sale	27.25	28	763	3,706	Feb 01 04:18 PM
Boulding Mark Elliott	EXEC. VP AND CLO	Jan 30 '24	Sale	27.25	794	21,637	71,189	Feb 01 04:17 PM
Pauwels Eric	CHIEF BUSINESS OFFICER	Jan 30 '24	Sale	27.25	366	9,974	44,181	Feb 01 04:16 PM
Utter Christine Marie	SVP, CHIEF ACCOUNTING OFFICER	Jan 30 '24	Sale	27.25	318	8,666	35,528	Feb 01 04:15 PM
Jacobson Allan Steven	Director	Jan 22 '24	Option Exercise	27.05	10,000	270,500	22,348	Jan 24 04:30 PM
Jacobson Allan Steven	Director	Jan 22 '24	Sale	27.38	10,000	273,804	12,348	Jan 24 04:30 PM
Utter Christine Marie	SVP, FINANCE & CAO	Jan 09 '24	Sale	29.01	1,653	47,961	35,846	Jan 10 04:11 PM
Utter Christine Marie	SVP, FINANCE & CAO	Jan 08 '24	Sale	28.64	1,188	34,025	37,499	Jan 10 04:11 PM
SCHMERTZLER MICHAEL	Director	Jan 08 '24	Sale	27.81	1,500	41,715	115,266	Jan 10 04:10 PM
Pauwels Eric	CHIEF BUSINESS OFFICER	Jan 09 '24	Sale	29.01	2,065	59,916	44,547	Jan 10 04:09 PM
Pauwels Eric	CHIEF BUSINESS OFFICER	Jan 08 '24	Sale	28.64	1,569	44,937	46,612	Jan 10 04:09 PM
Klein Matthew B.	CHIEF EXECUTIVE OFFICER	Jan 09 '24	Sale	29.01	5,443	157,928	160,475	Jan 10 04:08 PM
Klein Matthew B.	CHIEF EXECUTIVE OFFICER	Jan 08 '24	Sale	28.64	2,237	64,068	165,918	Jan 10 04:08 PM
Golden Lee Scott	CHIEF MEDICAL OFFICER	Jan 09 '24	Sale	29.01	1,225	35,543	37,914	Jan 10 04:06 PM
Golden Lee Scott	CHIEF MEDICAL OFFICER	Jan 08 '24	Sale	28.64	775	22,196	39,139	Jan 10 04:06 PM
Boulding Mark Elliott	EXEC. VP AND CLO	Jan 09 '24	Sale	29.01	1,938	56,231	71,983	Jan 10 04:04 PM
Boulding Mark Elliott	EXEC. VP AND CLO	Jan 08 '24	Sale	28.64	1,457	41,729	73,921	Jan 10 04:04 PM
Almstead Neil Gregory	CHIEF TECHNICAL OPS OFFICER	Jan 09 '24	Sale	29.01	1,521	44,132	61,820	Jan 10 04:03 PM
Almstead Neil Gregory	CHIEF TECHNICAL OPS OFFICER	Jan 08 '24	Sale	28.64	1,236	35,399	63,341	Jan 10 04:03 PM
Almstead Neil Gregory	CHIEF TECHNICAL OPS OFFICER	Jan 09 '24	Sale	29.01	100	2,901	3,734	Jan 10 04:03 PM
Almstead Neil Gregory	CHIEF TECHNICAL OPS OFFICER	Jan 08 '24	Sale	28.64	53	1,518	3,834	Jan 10 04:03 PM
Klein Matthew B.	CHIEF EXECUTIVE OFFICER	Jan 05 '24	Sale	27.15	10,107	274,393	168,155	Jan 09 04:29 PM
Gravier Pierre	CHIEF FINANCIAL OFFICER	Dec 12 '23	Buy	25.81	7,700	198,736	33,700	Dec 14 04:38 PM

NXGL

Nexgel Inc

PTCT

PTC Therapeutics Inc

Upgrade your FINVIZ experience